Debut Plus

₹325.85

▼ -7.84 -2.35%

As of 23 Oct 2026 · delayed

BSE Listed

Titan Biotech Ltd. (524717)

Volume: 24,929Avg Vol 1W: 48,230Avg Vol 1M: 24,48552W Range:₹171.4₹555.65
BSE www.titanbiotechltd.com AI Report
Key Ratios
Checked 3h ago
Market Cap₹1,683 Cr
Current Price₹325.85
Previous Close₹333.69
High / Low (52w)₹555.65 / ₹171.4
Volume24,929
Avg Vol (1W)48,230
Avg Vol (1M)24,485
Stock P/E39.74
Book Value₹35.15
Dividend Yield12%
ROE16.46%
ROA14.38%
Revenue (TTM)—
Revenue Growth—
Profit Margin15.48%
Total Debt—
Shares Outstanding5 Cr
Face Value—
EPS (TTM)₹6.56
P/B9.27
Debt / Equity0.03
50 DMA₹399.92
200 DMA₹375.91
Day change-2.35%
Price Chart
₹325.85▲ 42.55% · 1Y
₹529₹1663.9L
2025-10-27
2026-10-23

20-day avg volume: 25K shares

Pros
  • Healthy return on equity of 16.5%.
  • Pays a dividend yield of 12.0%.
  • Company is almost debt-free.
  • Revenue grew 21% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹40 Cr₹38 Cr₹35 Cr₹47 Cr₹54 Cr₹57 Cr₹49 Cr₹59 Cr
EBITDA₹7 Cr₹5 Cr₹5 Cr₹8 Cr₹9 Cr₹11 Cr₹11 Cr₹13 Cr
Net Profit₹7 Cr₹4 Cr₹4 Cr₹7 Cr₹8 Cr₹9 Cr₹7 Cr₹11 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹160 Cr₹35 Cr₹47 Cr₹54 Cr₹57 Cr₹49 Cr₹212 Cr₹59 Cr
EBITDA₹25 Cr₹5 Cr₹8 Cr₹9 Cr₹11 Cr₹11 Cr₹39 Cr₹13 Cr
Net Profit₹22 Cr₹4 Cr₹6 Cr₹7 Cr₹8 Cr₹7 Cr₹30 Cr₹9 Cr
EPS26.06—————7.23—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹65 Cr₹76 Cr₹101 Cr₹108 Cr₹135 Cr₹157 Cr₹175 Cr₹214 Cr
Total Liabilities₹31 Cr₹34 Cr₹28 Cr₹22 Cr₹25 Cr₹24 Cr₹21 Cr₹32 Cr
Equity₹34 Cr₹42 Cr₹72 Cr₹86 Cr₹110 Cr₹133 Cr₹153 Cr₹182 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹7 Cr₹8 Cr₹30 Cr₹29 Cr₹29 Cr₹29 Cr₹26 Cr₹39 Cr
Investing₹-4 Cr₹-2 Cr₹-5 Cr₹-16 Cr₹-21 Cr₹-20 Cr₹-10 Cr₹-33 Cr
Financing₹0 Cr₹-4 Cr₹-11 Cr₹-4 Cr₹-2 Cr₹-3 Cr₹-8 Cr₹-2 Cr
Free Cash Flow₹7 Cr₹8 Cr₹30 Cr₹29 Cr₹29 Cr₹29 Cr₹26 Cr₹39 Cr
Shareholding
Promoter 55.78% Institutions 0.01% Public 44.21%
Efficiency & Working Capital
ROCE20.9%
Interest Coverage43
Dividend Payout—
Debtor Days40 d
Inventory Days99 d
Payable Days15 d
Cash Conversion Cycle124 d
Working Capital Days139 d
Shareholding Details

As of 2026-09-30

Promoter55.8%
FII0%
DII0%
Institutions0%
Public44.2%
Promoter Pledge0%
No. of Shareholders19,049
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters55.9%55.9%55.9%55.9%55.9%55.9%55.9%55.8%55.8%55.8%55.8%55.8%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0.2%0%0%0%0%0%0%0%0%0%0%
Public44.1%43.9%44.1%44.1%44.1%44.1%44.1%44.2%44.2%44.2%44.2%44.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders15,75615,87615,85015,70016,03816,37016,32816,04016,36717,45718,67119,049
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Titan Securities LimitedShareholding of Promoter and Promoter Group33.6%1.39 Cr
Tanita Leasing & Finance LimitedShareholding of Promoter and Promoter Group9.5%39,22,275
Investor Education And Protection Fund Authority Ministry Of Corporate AffairsPublic Shareholding9.4%38,73,525
Connoisseur Management Services Private LimitShareholding of Promoter and Promoter Group6.8%28,00,000
Manish GoelPublic Shareholding2.8%11,61,442
Titan Biotech Limited Unclaimed Suspense Demat AccountPublic Shareholding2.3%9,52,005
Suresh Chand SinglaShareholding of Promoter and Promoter Group1.3%5,28,355
Manju SinglaShareholding of Promoter and Promoter Group0.9%3,56,050
Madhu GuptaShareholding of Promoter and Promoter Group0.8%3,32,550
Raja SinglaShareholding of Promoter and Promoter Group0.7%3,05,500
Supriya SinglaShareholding of Promoter and Promoter Group0.7%2,72,465
Udit SinglaShareholding of Promoter and Promoter Group0.6%2,50,000
Shivom SinglaShareholding of Promoter and Promoter Group0.4%1,77,000
Naresh Kumar SinglaShareholding of Promoter and Promoter Group0.4%1,72,550
Naresh Kumar Singla HufShareholding of Promoter and Promoter Group0.1%50,000
Ravinder Gupta HufShareholding of Promoter and Promoter Group0%0
Ravinder GuptaShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Rohit JainChairman & Independent Directo2025
Naresh Kumar SinglaED / MD / Promoter2025
Suresh Chand SinglaED / MD / Promoter2025
Manju SinglaNon-Exec & Non-Independent Dir2025
Supriya SinglaNon-Exec & Non-Independent Dir2025
Dhairya MadanIndependent Non Exe. Director2025
Brijesh Kumar SinghIndependent Non Exe. Director2025
Abhishek AgarwalIndependent Non Exe. Director2025
Raja SinglaWTD & Executive Director2025
Udit SinglaE D & Wholetime Director2025
Shivom SinglaE D & Wholetime Director2025
Debendra Kumar SabatIndependent Non Exe. Director2025
CHARANJIT SINGHCompany Sec. & Compli. Officer2025
Segments — Geography
RegionRevenueShare
Domestic₹126 Cr61%
Overseas₹80 Cr39%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹21088
Corporate Actions
TypeDateValueRemark
forthcoming2026-10-23Bonus—
bonus2026-10-231:41:4 Bonus Issue of Equity Shares
dividend2026-09-22₹0.5 (25%)Final
forthcoming2026-09-22Dividend—
forthcoming2026-08-13Board Meetings—
split2026-02-201:5face value change from 10 to 2
dividend2025-09-19₹2 (20%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026016074063
2026090009
202603073949
Insider / Designated-Person Trades

1 recent disclosure(s)

RAVINDER GUPTA HUFDisposal · 21
Company Information
Incorporated1992
ChairmanRohit Jain
AuditorA N S K & Associates
Investor Email[email protected]
🌐 www.titanbiotechltd.com ↗

📍 A-902 A RIICO Industrial Area, Phase III Alwar District, Bhiwadi, Rajasthan, 301019

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Savita Oil TechnologiesKabsons Industries Ltd.Basant Agro Tech (India) Ltd.Sandu Pharmaceuticals Ltd.Vista Pharmaceuticals Ltd.Sun PharmaceuticalArvaya Healthcare Ltd.Span Divergent LimitedJenburkt Pharmaceuticals Ltd.HikalCaplin Point LaboratoriesFischer Medical VenturesAll “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search